- 不限
- 2025年07月04日 [星期五]
- 2025年07月05日 [星期六]
- 2025年07月06日 [星期日]
- 不限
- 3F-国际会议厅301EFGH
- 6F-国际会议四厅603A
- 6F-国际会议四厅603B
- 6F-国际会议四厅603AB
2025年07月05日 [星期六]
6F-国际会议四厅603A
| 1 | 13:00-13:03 | 壁报发言 |
基于巨噬细胞异质性的肺纤维化发病机制：亚群特异性通路与靶向治疗新策略 |
|
||||
| 2 | 13:00-13:03 | 壁报发言 |
ISM1通过调节脂肪酸代谢减轻肺纤维化 |
|
||||
| 3 | 13:06-13:09 | 壁报发言 |
Research Landscape and Trends in Aging on Interstitial Lung Diseases: A Bibliometric Analysis |
|
||||
| 4 | 13:09-13:12 | 壁报发言 |
Matrix Metalloproteinases levels in induced sputum in IPF and CTD-ILD |
|
||||
| 5 | 13:12-13:15 | 壁报发言 |
A prognostic model of patients with MDA5-positive dermatomyositis-associated interstitial lung disease: a multicenter retrospective cohort study in China |
|
||||
| 6 | 13:15-13:18 | 壁报发言 |
Developing and Validation of a Multimodal-based Machine Learning Model for Diagnosis of Usual Interstitial Pneumonia: a Prospective Multicenter Study |
|
||||
| 7 | 13:18-13:21 | 壁报发言 |
The prevalence and unique clinical features of CPFE among patients with connective tissue disease-associated interstitial lung disease-A retrospective, real-world study |
|
||||
| 8 | 13:21-13:24 | 壁报发言 |
基于炎症-营养学对特发性肺纤维化合并肺癌患者的生存预后分析 |
|
||||
| 9 | 13:24-13:27 | 壁报发言 |
68Ga-FAPI-04 PET/CT in the Evaluation of Fibrosis Activation and Clinical Feature Correlation in Anti-MDA5 Positive Dermatomyositis-Associated Interstitial Lung Disease |
|
||||
| 1 | 14:00-14:15 | 专题发言 |
2024-2025ATS/ERS大会ILD领域新进展 |
|
||||
| 2 | 14:15-14:30 | 专题发言 |
PET-CT在ILD诊疗应用进展 |
|
||||
| 3 | 14:30-14:45 | 专题发言 |
ILD新型诊断工具的开发与临床应用前景 |
|
||||
| 4 | 14:45-15:00 | 专题发言 |
从生物标志物到ILD个体化生存预测 |
|
||||
| 5 | 15:00-15:15 | 专题发言 |
过敏性肺炎的诊疗进展 |
|
||||
| 6 | 15:15-15:20 | 论文发言 |
基于多光子显微成像的胶原定量表征预测肺纤维化进展 |
|
||||
| 7 | 15:20-15:25 | 论文发言 |
SDC1介导TG2核转位激活NF-κB通路促进肺泡上皮细胞损伤与肺纤维化机制研究 |
|
||||
| 8 | 15:25-15:30 | 论文发言 |
Single-Cell Transcriptomics Reveals Dual Role of CD40L+CD4+ T Cells in Immunosuppression and Fibrosis in Idiopathic Pulmonary Fibrosis |
|
||||
| 9 | 15:30-15:35 | 论文发言 |
巴瑞替尼抑制M2型巨噬细胞极化后，miR-126a-3p分泌增多从而缓解RA-ILD |
|
||||
| 10 | 15:35-15:40 | 论文发言 |
ITIH5high巨噬细胞活化成纤维细胞Smad2/3促进肺纤维化 |
|
||||
| 11 | 15:40-15:45 | 论文发言 |
Cholesterol Metabolic Reprogramming Drives the Switch from Pro-inflammatory to Repair Phenotype in Macrophages of Fibrotic Lungs |
|
||||
| 12 | 15:45-16:00 | 讨论 |
讨论 |
|||||
| 1 | 16:00-16:15 | 专题发言 |
基于可治疗特征驱动的ILD动态管理 |
|
||||
| 2 | 16:15-16:30 | 专题发言 |
ILD与共病的管理策略 |
|
||||
| 3 | 16:30-16:45 | 专题发言 |
肺康复治疗在ILD患者中的循证实践路径 |
|
||||
| 4 | 16:45-17:00 | 专题发言 |
抗纤维化在CTD-ILD治疗中的地位 |
|
||||
| 5 | 17:00-17:15 | 专题发言 |
肺移植评估时机的临床决策树构建 |
|
||||
| 6 | 17:15-17:20 | 论文发言 |
NUFIP1 介导的核糖体自噬在特发性肺纤维化发病机制中的作用研究 |
|
||||
| 7 | 17:20-17:25 | 论文发言 |
Carbonic Anhydrase 4 maintains aerocyte identity to attenuate lung fibrosis |
|
||||
| 8 | 17:25-17:30 | 论文发言 |
1,25(OH)2D3 inhibits proliferation and migration of TSC2-/- cells through VDR modulation of the ER-ERK signaling axis |
|
||||
| 9 | 17:30-17:35 | 论文发言 |
天麻素通过激活PINK1/Parkin介导的线粒体自噬缓解肺泡上皮细胞EMT改善肺纤维化的作用与机制研究 |
|
||||
| 10 | 17:35-17:40 | 论文发言 |
AAV-Mediated PRDM16 Gene Therapy Attenuates Pulmonary Fibrosis via PPM1A-Dependent SMAD3 Dephosphorylation in Lung Fibroblasts |
|
||||
| 11 | 17:40-17:45 | 论文发言 |
全基因组CRISPR screen鉴定DTX4通过调控肺泡巨噬细胞胆固醇外排参与肺泡蛋白沉积症发生发展 |
|
||||
| 12 | 17:45-18:00 | 讨论 |
讨论 |
|||||